2021 Rheumatology Year in Review: New FDA Approvals and Indications, Biologics for Lupus & GCA, Hydroxychloroquine, IL-23 Inhibitors and JAK Inhibitor Warnings

By RheumNow FEATURING John J. Cush
By RheumNow FEATURING John J. Cush
280 views
January 14, 2022
Comments 0
Login to view comments. Click here to Login